QUALIBLOOD
The KBO register records legal situation 012 for QUALIBLOOD (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 8 yrs |
| Board | 14 |
| Locations | 1 |
| Publications | 8 |
Dissolution or liquidation
The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 07-05-2025 | 2025-00089739 |
| 31-12-2023 | volledig | 09-07-2024 | 2024-00224799 |
| 31-12-2022 | volledig | 15-06-2023 | 2023-00132892 |
| 31-12-2021 | volledig | 23-08-2022 | 2022-20319406 |
| 31-12-2020 | volledig | 06-05-2021 | 2021-13400476 |
| 31-12-2019 | volledig | 17-04-2020 | 2020-09300454 |
| 31-12-2018 | volledig | 29-04-2019 | 2019-11200062 |
-
WinAndGrowLegal entityManaging director· perm. rep.: WINAND JulieState Gazette act 24388725 (16-04-2024)Current01-04-2024 → present
-
CENTRE HOSPITALIER UNIVERSITAIRE DINANT GODINNE SAINTE-ELISABETH-UCL-NAMURLegal entityDirector· perm. rep.: DE SAINT-HUBERT MarieState Gazette act 24388725 (16-04-2024)Current26-03-2024 → present
-
Conseils, Gestion, organisationLegal entityDirector· perm. rep.: DELAUNOIS PhilippeState Gazette act 24388725 (16-04-2024)Current26-03-2024 → present
-
NAMUR INVESTLegal entityDirector· perm. rep.: LIEVENS Pierre-YvesState Gazette act 24388725 (16-04-2024)Current26-03-2024 → present
-
NOSHAQ PARTNERSLegal entityDirector· perm. rep.: SABATEL HélèneState Gazette act 24388725 (16-04-2024)Current26-03-2024 → present
-
PHARMXPERTISELegal entityDirector· perm. rep.: DOUXFILS JonathanState Gazette act 24388725 (16-04-2024)Current26-03-2024 → present
Show 8 more sitting directors
-
Current26-03-2024 → present
-
Current14-11-2023 → present
-
Current14-11-2023 → present
2 events
- 14-11-2023 Appointed· Director
- 31-12-2020 Resigned· Director
-
Current14-11-2023 → present
2 events
- 26-03-2024 Mandate renewed· Director
- 14-11-2023 Appointed· Director
-
Namur Invest PréfaceLegal entityDirector· perm. rep.: Pierre-Yves LIEVENSState Gazette act 23159403 (13-12-2023)Current14-11-2023 → present
-
Current14-11-2023 → present
-
Current03-05-2023 → present
3 events
- 26-03-2024 Appointed· Director
- 14-11-2023 Appointed· Director
- 03-05-2023 Appointed· Director
-
PHARMXPERTISELegal entityDirector· perm. rep.: DOUXFILS JonathanState Gazette act 20366833 (31-12-2020)Current31-12-2020 → present
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 15-11-2017 |
| Status | Active |
| Postal code | 4000 |
Show 2 more companies with a shared director
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62042B0366/00B003 | Wallonia | 1.9 ha | - | - |
| 62803B0206/00G002 | Wallonia | 807 m² | 1 · 128 m² | 26.3 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
01-04-2026 Act object · Seat change
- Act object: Transfert du siège social · QUALIBLOOD
- Seat change: new_address: 4000 Liège, rue Louvrex, 55/57, decision_date: 2026-03-11 · QUALIBLOOD
- Filing: date: 2026-03-18, court: TRIBUNAL DE L'ENTREPRISE DE LIEGE · QUALIBLOOD
- Publication: date: 2026-04-01, gazette: Moniteur belge · QUALIBLOOD
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Transfert du si\u00E8ge social",
"value": "Transfert du si\u00E8ge social",
"object": null,
"subject": "QUALIBLOOD"
},
{
"type": "seat_change",
"quote": "Par jugement du 11 mars 2026, le Tribunal de l\u0027entreprise de Li\u00E8ge - division Li\u00E8ge a homologu\u00E9 le transfert du si\u00E8ge de la soci\u00E9t\u00E9 QUALIBLOOD en liquidation au cabinet du liquidateur situ\u00E9 \u00E0 4000 Li\u00E8ge, rue Louvrex, 55/57.",
"value": {
"new_address": "4000 Li\u00E8ge, rue Louvrex, 55/57",
"decision_date": "2026-03-11"
},
"object": null,
"subject": "QUALIBLOOD"
},
{
"type": "filing",
"quote": "18 MARS 2026 BUNAL DE L\u0027ENTREPRISE DE LIE Greffe",
"value": {
"date": "2026-03-18",
"court": "TRIBUNAL DE L\u0027ENTREPRISE DE LIEGE"
},
"object": null,
"subject": "QUALIBLOOD"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 01/04/2026 - Annexes du Moniteur belge",
"value": {
"date": "2026-04-01",
"gazette": "Moniteur belge"
},
"object": null,
"subject": "QUALIBLOOD"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1022,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "QUALIBLOOD",
"kbo": "0684.698.353",
"kind": "company",
"name": "QUALIBLOOD",
"attrs": {
"status": "en liquidation",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "Roman AYDOGDU",
"kbo": null,
"kind": "person",
"name": "Roman AYDOGDU",
"attrs": {
"role": "liquidateur"
}
}
]
}04-12-2025 Dissolution of the company
Technical details
{
"events": [
{
"date": "2025-10-28",
"kind": "ontbinding",
"liquidators": [
{
"name": "Ma\u00EEtre Roman AYDOGDU",
"role": "vereffenaar"
}
],
"evidence_quote": "L\u0027assembl\u00E9e d\u00E8cide que la soci\u00E9t\u00E9 anonyme \u00AB QUALIBLOOD \u00BB ... est dissoute et entre en liquidation \u00E0 dater de ce jour."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"final_status": "in_vereffening",
"subject_company": {
"kbo": "0684.698.353"
}
}16-04-2024 Registered office moved from Namur to Liège
- Rue du Séminaire 20, 5000 Namur → Boulevard Patience & Beaujonc 3, 4000 Liège
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Li\u00E8ge",
"region": null,
"street": "Boulevard Patience \u0026 Beaujonc",
"country": "BE",
"postcode": "4000",
"box_number": null,
"street_number": "3"
},
"old_address": {
"city": "Namur",
"region": null,
"street": "Rue du S\u00E9minaire",
"country": "BE",
"postcode": "5000",
"box_number": "A",
"street_number": "20"
},
"effective_date": "2024-03-28",
"evidence_quote": "La Conseil d\u0027administration d\u00E9cide de d\u00E9placer le si\u00E8ge social \u00E0 l\u0027adresse suivante : L\u00E9giapark (aile Ouest), 3 Boulevard Patience \u0026 Beaujonc, 4000, Li\u00E8ge"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0684.698.353",
"name_full": "QUALIBLOOD",
"legal_form": "SA"
}
}13-12-2023 6 directors appointed
- Jonathan DOUXFILS, Bestuurder
- Jean-Michel FOIDART, Bestuurder
- Bernard MASEREEL, Bestuurder
- Philippe DELAUNOIS, Bestuurder
- Pierre-Yves LIEVENS, Bestuurder
- Marie de SAINT-HUBERT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jonathan DOUXFILS",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Michel FOIDART",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bernard MASEREEL",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, Messieurs Jonathan DOUXFILS, Jean-Michel FOIDART et Bernard MASEREEL sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe DELAUNOIS",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, Monsieur Philippe DELAUNOIS, repr\u00E9sentant CGO SA, est nomm\u00E9 administrateur de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre-Yves LIEVENS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Namur Invest Preface",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, la soci\u00E9t\u00E9 anonyme \u003C NAMUR INVEST PREFACE \u003E avec pour repr\u00E9sentant permanent Monsieur Pierre-Yves LIEVENS et Madame Marie de SAINT-HUBERT, repr\u00E9sentante du CHU UCL Namur, sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marie de SAINT-HUBERT",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-14",
"evidence_quote": "En cons\u00E9quence, la soci\u00E9t\u00E9 anonyme \u003C NAMUR INVEST PREFACE \u003E avec pour repr\u00E9sentant permanent Monsieur Pierre-Yves LIEVENS et Madame Marie de SAINT-HUBERT, repr\u00E9sentante du CHU UCL Namur, sont nomm\u00E9s administrateurs de QUALIblood SA du 14 novembre 2023 jusqu\u0027au 28 mars 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0684.698.353",
"name_full": "QUALIBLOOD",
"legal_form": "SA"
}
}03-05-2023 Jean-Michel FOIDART appointed as director
- Jean-Michel FOIDART, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Michel FOIDART",
"address": null,
"birth_date": null
},
"evidence_quote": "A l\u0027unanimit\u00E9 des membres pr\u00E9sents et repr\u00E9sent\u00E9s, l\u0027assemb\u00E9e approuve la nomination de Jean-Michel FOIDART comme administrateur jusqu\u0027au 14-11-2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0684.698.353",
"name_full": "QUALIBLOOD",
"legal_form": "SA"
}
}31-12-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": true,
"object_change": false,
"effective_date": "2020-12-08",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0684.698.353",
"name_full": "QUALIBLOOD",
"legal_form": "SA"
},
"signature_regime": "joint_by_class",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}01-12-2020 Board meeting · Power of attorney
- Publication: 01/12/2020 · Centre Hospitalier Universitaire UCL Dinant Godinne Sainte-Elisabeth
- Filing: 23/11/2020 · Centre Hospitalier Universitaire UCL Dinant Godinne Sainte-Elisabeth
- Board meeting: 17/09/2020 · Centre Hospitalier Universitaire UCL Dinant Godinne Sainte-Elisabeth
- Power of attorney: représentant de l'asbl CHU UCL Namur au sein de l'assemblée générale de Qualiblood · Benoît Libert
- Power of attorney: représentant de l'asbl CHU UCL Namur au sein de l'assemblée générale de Qualiblood · Alexis Ghysels
Technical details
{
"facts": [
{
"date": "2020-12-01",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblac ad - 01/12/2020 - Annexes du Moniteur belge",
"value": "01/12/2020",
"object": null,
"subject": "e1"
},
{
"date": "2020-11-23",
"type": "filing",
"quote": "D\u00E9pos\u00E9 au greffe du Tribunal de l\u0027entreprise de Li\u00E8ge, division Dinant le 23/11/2020",
"value": "23/11/2020",
"object": null,
"subject": "e1"
},
{
"date": "2020-09-17",
"type": "board_meeting",
"quote": "le Conseil d\u0027administration r\u00E9uni le 17/09/2020",
"value": "17/09/2020",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "d\u00E9signe Monsieur Beno\u00EEt Libert ... repr\u00E9sentants de l\u0027asbl CHU UCL Namur au sein de l\u0027assembl\u00E9e g\u00E9n\u00E9rale de Qualiblood",
"value": "repr\u00E9sentant de l\u0027asbl CHU UCL Namur au sein de l\u0027assembl\u00E9e g\u00E9n\u00E9rale de Qualiblood",
"object": "e1",
"subject": "e2"
},
{
"type": "power_of_attorney",
"quote": "d\u00E9signe ... Monsieur Alexis Ghysels ... repr\u00E9sentants de l\u0027asbl CHU UCL Namur au sein de l\u0027assembl\u00E9e g\u00E9n\u00E9rale de Qualiblood",
"value": "repr\u00E9sentant de l\u0027asbl CHU UCL Namur au sein de l\u0027assembl\u00E9e g\u00E9n\u00E9rale de Qualiblood",
"object": "e1",
"subject": "e3"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1436,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0641.733.885",
"kind": "company",
"name": "Centre Hospitalier Universitaire UCL Dinant Godinne Sainte-Elisabeth",
"attrs": {
"seat": "Avenue Docteur Th\u00E9rasse, 1-5530 Yvoir",
"legal_form": "ASBL",
"short_name": "CHU UCL NAMUR"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Beno\u00EEt Libert",
"attrs": {
"role": "directeur g\u00E9n\u00E9ral du CHU UCL Namur"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Alexis Ghysels",
"attrs": {
"role": "directeur administratif et financier du CHU UCL Namur"
}
},
{
"id": "e4",
"kbo": "0684.698.353",
"kind": "company",
"name": "Qualiblood Soci\u00E9t\u00E9 Anonyme",
"attrs": {
"seat": "Rue du S\u00E9minaire 20a - 5000 Namur",
"legal_form": "Soci\u00E9t\u00E9 Anonyme"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Jean-Marc DIEU",
"attrs": {
"role": "Pr\u00E9sident"
}
}
]
}17-11-2017 Incorporation of a new SNC
Technical details
{
"kind": "oprichting",
"seat": "Namur, rue du S\u00E9minaire 20a",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1988-07-11",
"name": "Jonathan DOUXFILS",
"niss": null,
"address": "Courri\u00E8re, rue des Grands Joncs, 27"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 16000,
"holder_person_name": "Jonathan DOUXFILS",
"is_subscriber_only": false,
"n_shares_subscribed": 1600,
"amount_subscribed_eur": 16000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1988-12-07",
"name": "Damien Claude GHELDOF",
"niss": null,
"address": "Floreffe/Floriffoux, rue Jules-Theunis, 3"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 12000,
"holder_person_name": "Damien Claude GHELDOF",
"is_subscriber_only": false,
"n_shares_subscribed": 1200,
"amount_subscribed_eur": 12000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "BIOPHA"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "BIOPHA",
"contribution_type": "cash",
"amount_paid_in_eur": 6000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 600,
"amount_subscribed_eur": 6000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "CONSEILS, GESTION, ORGANISATION"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "CONSEILS, GESTION, ORGANISATION",
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 10000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "UNAMUR VENTURE"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "C",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "UNAMUR VENTURE",
"contribution_type": "cash",
"amount_paid_in_eur": 54000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 5400,
"amount_subscribed_eur": 54000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0641.733.885",
"name": "Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth \u2013 UCL - Namur"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "C",
"partner_role": null,
"holder_org_kbo": "0641.733.885",
"holder_org_name": "Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth \u2013 UCL - Namur",
"contribution_type": "cash",
"amount_paid_in_eur": 12000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1200,
"amount_subscribed_eur": 12000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 110000,
"subject_company": {
"kbo": "0684.698.353",
"name_full": "QUALIBLOOD",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2017-11-14",
"post_incorporation_mandates": []
}| Legal nameFR | QUALIBLOOD |